WARNING: WORLD CLASS ANALYSIS POST I’m only half a

New Post Public Reply Private Reply Replies (4) Message Board
Respert24
1,023
WARNING: WORLD CLASS ANALYSIS POST

I’m only half a bottle of St. Francis Cabernet into the evening so I’ll apologize in advance if this makes more sense than normal.

I got the latest SEC filing straight to my inbox earlier. Felt good. Hit it right in the sweet spot.

Then, like I do every time I get an email about a new filing I rush to open it up on my phone (which is what I’m usually on when these hit) and immediately start pretending like I know what the hell I’m looking at.

“Hmmm, yeah, yeah, definitely good stuff here”, I say to myself as I have to constantly zoom in and out on the 2pt font to see what the hell it says. “Must be related to the uplisting.”

Then I rush over here to see what people who aren’t me say. If it’s close to what I was guessing I get very impressed with myself.

Anyways, let’s talk about tomorrow!

Many of you haven’t been made aware (wine-induced sarcasm*) but there are a couple upcoming events related to our investments in CYDY. Tomorrow there will be a conference call to discuss updates related to ongoing efforts toward approval. Also, by the end of the month we’ll all need to vote on whether or not to sprinkle more gold on the already Scrooge McDuck-sized pool of coins at the executive gym down the street from the home office. They spray hospital grade sanitizer on the coins in between each board of director’s swim, so it’s safe. Not that they couldn’t just pull out the leronlimab vial they each carry in their suit pockets and self-inject themselves back to 100%, but you can never be too safe.

*Medical Term

(2/3rds of a bottle)

It’s probably a good idea to assume nothing good is going to come of the call so that you’re impressed when it’s over rather than disappointed.

Oh me?

I think we’re going to get something substantial.

I ran a binomial reduction of possibilities, cross referenced those against a standard Kruskal Wallis test (Thanks Google!), and then input those values into my premier league simulation software to check the results. My striker, Respert (Number 24, obviously) led the league in goals and had just nutmegged a defender when my computer screen went blue and asked if I wanted to restart in safe mode. So I think it’s “safe” to say that we’re totally going to get a major announcement tomorrow.

But what will it be?

Well, you heard it here first that…

I honestly don’t know.

But...BUT...I think we actually do get an announcement of the UK advancing Leronlimab toward approval. Something that becomes trackable and imminent. Maybe NASDAQ happens on the call, too. But regardless of the exact announcement I believe we will get something substantial toward approval and revenue. And if we don’t get anything negative (like the US or the UK declining to give us EUA, or NASDAQ telling us to shove it) we should be happy that after 30-ish days waiting on approval we haven’t been told no. That in and of itself should be a glaring positive that it’s going to get done. 30 days seems to be the reasonable timeframe for a decision. Why wait that long just to say no?

At any rate, I’m sick and tired of waiting like the rest of you. Beach houses don’t buy themselves and until I give the wife a beach house to decorate I’m stuck getting the investing equivalent of blue balls every time I wake up at 5:15 and stare at my phone until 6:00 for no PR. But as long as there isn't a roadblock thrown our way tomorrow I'll be happy. Progress is important.

(Full bottle complete)

In conclusion, now that I’m out of wine, I wish I had more facts, advice, and actionable information for you but I don’t. Just a little guess and a whole lot of fluff. Though I will predict that once we get approval we will see both an immediate jump in share price AND a steady move higher as more and more people learn about CYDY from the resulting news and jump onboard. So if you see it jump to, say, $19 with the news on the first day, I would predict that over the next 3-5 days there’s another significant increase as awareness spreads. This is why it will be difficult for me to know for sure when I pull out a small percentage of my shares to cover my initial investment or fund a pool. Not to mention that any approval brings the increased chances that all the other possibilities are more realistic than where they stand today, and that’s worth something too.

I’ll probably drink another bottle of wine tomorrow night after the call. Maybe I’ll post. I guess the question is, will it be a $15-$20 bottle of wine or a much more expensive one?

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Victory Capital Faces Legal Scrutiny Over $7B Deal

Updated Category News Views 2

Victory Capital's $7 Billion Gamble Under the Microscope New day, new twist in the financial soap opera we call mergers and acquisitions. This time, the spotlight shines on Victory Capital Holdings, Inc. (NASDAQ: VCTR) and its big-dollar dance to acquire First Eagle for a whopping $7 billion. Now, Juan Monteverde, Esq., and his team over at Monteverde & Associates PC have...

Continue Reading
Tahoe Truckee Life TV Series Elevates Local Flavor

Updated Category News Views 2

Meet “Tahoe Truckee Life” Kane Schaller, the face of the Tahoe Truckee Life series, is giving folks a front-row seat to the lives and landscapes that make the Reno-Tahoe region buzz. Now, I've seen shows trying to pull this off, but this one might just spark something genuine if done right. The Real Deal on Reno-Tahoe The show airs on the REAL Shows Network—a...

Continue Reading
HIMS Faces Class Action: Investors Eye Leadership

Updated Category News Views 3

Another Day, Another Lawsuit: Hims & Hers in Hot Water Here's the latest conundrum in the corporate world, folks. Hims & Hers Health, Inc. (NYSE: HIMS) is caught up in a class action lawsuit that could shake up the telehealth scene. Investors who found themselves knee-deep in losses during the class period from August 2025 to July 2026 might want to pay attention. The...

Continue Reading
Vanda Pharmaceuticals Steps Into September Investor Talks

Updated Category News Views 3

Vanda Pharmaceuticals Heads Into Key Investor Spotlights In the relentless quest for market edge, Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is setting the stage for what could be some telling moments in September 2026. Investors with a keen interest in the pharmaceutical realm should seat themselves upfront as Vanda takes the floor in a series of pivotal conferences. Each...

Continue Reading
Truist Revolutionizes Banking with 2 Billion Insights

Updated Category News Views 1

A New Frontier in Banking Truist is out here flipping the script in digital banking, pushing a staggering 2 billion AI-driven insights since 2023. Imagine that—two billion insights 'till now, providing the kind of financial street smarts that help folks feel less like they're lost at sea and more like they're the captain of their own financial ship, all thanks to Truist...

Continue Reading
Royal Mint Ventures Into the Final Frontier with Star Trek Coins

Updated Category News Views 2

A Cosmic Coin Collection for the Ages The Royal Mint has stepped boldly into a realm where no coin has gone before—celebrating six decades of Star Trek with two new collectable 50p coins. For Star Trek fans who’ve followed the Enterprise to the furthest reaches of the galaxy, these coins aren’t just chump change—they’re keepsakes that capture a piece of sci-fi...

Continue Reading
Check Point Shareholders Back 2026 AGM Proposals

Updated Category News Views 3

Shareholder Endorsement Solidifies Check Point's Strategy Today, Check Point Software Technologies had a bit of a celebratory mood. Their stakeholders, it seems, aren't just riding the wave; they're all in. You could almost hear the cheers from Redwood City when those shareholder voting results flashed across the board. Some 81.2 million shares—encompassing about 79.52%...

Continue Reading
Rodeo Dental Gears Up for National Growth Surge

Updated Category News Views 0

Rodeo Dental's Leadership Shuffle When you're talking about upping the ante in the dental world, you can't ignore the recent shake-up at Rodeo Dental & Orthodontics. They've decided to retool their corner office lineup, and this is where the folks in suits meet the folks with the steady hands in teeth. Co-Founder Dr. Saam Zarrabi is stepping into an Executive Chairman...

Continue Reading
Narwal Unveils 2026 AI Cleaning Lineup at IFA Berlin

Updated Category News Views 0

A Fresh Sweep with AI: Narwal's 2026 Lineup Hot off the press from Berlin's IFA 2026, Narwal is making some serious waves with its latest household cleaning gadgets. This isn't just another batch of robot helpers; Narwal's aiming to redefine what AI-driven cleaning can do for your home. FlowWash: Not Just Another Cleaning Gimmick Narwal's been at this game for over a...

Continue Reading
Hydrogen Mobility Gains Steam: Industry & Policy Unite

Updated Category News Views 2

The winds are changing, and this time, it's hydrogen that's blowing into town. Europe may just be on the brink of a major trucking overhaul, driven by a concoction of industry giants and supportive policies. The stage is set for hydrogen trucks to roll out by 2030, aiming to gut traditional fuel options and stack the odds in favor of zero-emission transport. Can you smell...

Continue Reading

Top 5 Most Recently Viewed Articles

Greenbrier's Commitment: $0.30 Dividend and Financial Growth

Updated Category News Views 40

Greenbrier Declares $0.30 Quarterly Dividend Greenbrier Companies has made a notable announcement regarding its dividend, revealing a quarterly cash dividend of $0.30 per share. This dividend reflects the company’s strategy to uphold and enhance shareholder value, reinforcing its standing in the freight transportation sector. Overview of Greenbrier Companies Operating...

Continue Reading
Empire State Building Celebrates AKC's Milestone Anniversary

Updated Category News Views 164

Empire State Building Shines Bright for a Special Celebration The American Kennel Club (AKC) is marking its 140th anniversary in an unforgettable manner by illuminating the iconic Empire State Building in its signature colors of blue and white. This vibrant display is not just a celebration of a significant milestone for the AKC; it also underscores its dedication to...

Continue Reading
Greenberg Traurig Boosts Private Equity in Chicago

Updated Category News Views 7

Driving Force in Legal Circles So, it seems like Greenberg Traurig is pulling no punches in beefing up its Private Equity Practice over in the Windy City. With the addition of Neal Loughery and Curt Ostosh as shareholders, they've got some serious talent ready to steer through the busy waters of private equity deals. And although this might feel like just another deck...

Continue Reading
Charlie Lee Reflects on Litecoin's Journey and His Choices

Updated Category News Views 380

Charlie Lee's Journey with Litecoin Litecoin (CRYPTO: LTC) is gaining momentum with a potential exchange-traded fund (ETF) debut looming on Wall Street. However, its creator, Charlie Lee, recently expressed that the entire process was fraught with challenges, leading him to wish he had made different choices. Advice to His Younger Self Investment Strategies from Lee In a...

Continue Reading
Gatos Silver's Exploration Breakthroughs Spark Optimism for Future

Updated Category News Views 179

Gatos Silver took some big steps back in 2024, especially with its drilling efforts in the Los Gatos district of Mexico. Desks were buzzing after they dropped a report highlighting some solid mineralized intercepts at their Central Deeps target and some hopeful signs from the South-East Deeps zone at Cerro Los Gatos Mine. You know how these reports go—everyone was...

Continue Reading